Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01173
Species: Homo sapiens
Position : chr3:111274001-111275000
Year: 2025
Title: Enhancer activation from transposable elements in extrachromosomal DNA.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: colorectal adenocarcinoma
PMID:  41120733
MONDO: MONDO:0005008
Tissue: sigmoid colon
Tissue Ontology ID: UBERON:0001159
Cell Source: COLO320DM
CVCL ID: CVCL_0219
Cell Type: colon epithelial cell, adenocarcinoma-derived
Cell Ontology ID: CL:0011108
Experiment Type: Enhancer activity assay; Functional perturbation assay; Chromatin interaction assay; Endogenous enhancer perturbation
High Throughput Method: Hi-C; Nanopore ultra-long read sequencing; H3K27ac ChIP-seq; ATAC-seq; RNA-seq; CRISPRi screen
Low Throughput Method: Luciferase reporter assay; CRISPRi dCas9-KRAB; CRISPR-CATCH; RNA-FISH; ORCA imaging; RT-qPCR; CRISPRi; Reporter assay
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01182 chr3:111274001-111275000 sigmoid colon colon epithelial cell, adenocarcinoma-derived colorectal adenocarcinoma
Expression of Target Genes for the Enhancer